SCHEMBL5409607

SCHEMBL5409607

Cc1ccc(CCN(CCC(=O)O)C(=O)c2ccccc2-c2ccccc2C(=O)NCc2ccc(C)o2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
PKM P14618 3/20 0.42
MAPT P10636 3/20 0.42
POLB P06746 2/20 0.42
APOBEC3A P31941 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
PPARG P37231 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5402458 0.88 ALDH1A1 (0.55) ALDH1A1PPARGMEN1KMT2AKDM4E
SCHEMBL5418399 0.87 ALDH1A1 (0.57) ALDH1A1PPARGMEN1KMT2AKDM4E
SCHEMBL5399793 0.87 ALDH1A1 (0.57) ALDH1A1PPARGMEN1KMT2AKDM4E
SCHEMBL5408664 0.85 RAB9A (0.53) ALDH1A1PKMMAPTPOLBMEN1
SCHEMBL5394545 0.85 LMNA (0.46) ALDH1A1PKMMAPTPOLBHPGD
SCHEMBL5392409 0.84 ALDH1A1 (0.50) ALDH1A1MAPTPPARGKDM4EHPGD
SCHEMBL5402442 0.84 ALDH1A1 (0.50) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL5399508 0.84 ALDH1A1 (0.50) ALDH1A1MAPTKMT2AKDM4EHPGD
SCHEMBL5403803 0.83 NPC1 (0.51) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL5399040 0.83 TRPM8 (0.45) ALDH1A1MAPTKDM4EHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB ALDH1A1 1256/4885PKM 880/4885MAPT 457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.